CPT Code 10010: FNA biopsy with CT guidance, each additional lesion

Key Takeaways

CPT code 10010 is an add-on code (+10010) for fine needle aspiration biopsy with CT guidance, reported for each additional lesion beyond the first

CPT 10010 is always paired with base code CPT 10009 – it cannot be billed standalone. Only one base code applies per session, per imaging modality

NCCI Chapter 3 Section L12 prohibits reporting any FNA biopsy code (10004-10012, 10021) alongside a separate biopsy code for the same lesion

Pabau’s claims management software helps radiology and surgical practices track add-on code pairings, document imaging sessions, and reduce FNA claim denials

CPT code 10010: Official descriptor and clinical overview

CPT code 10010 is an add-on code for fine needle aspiration biopsy with CT guidance, reported for each additional lesion sampled beyond the first. The official descriptor, maintained by the American Medical Association (AMA), reads: Fine needle aspiration biopsy, including CT guidance; each additional lesion (List separately in addition to code for primary procedure).

The “+” prefix confirms its add-on status, and it must always be billed with base code CPT 10009 – never for the first lesion, and never on its own.

This reference covers the billing rules, NCCI bundling restrictions, documentation requirements, and reimbursement context coders need to submit clean claims. The same add-on code logic recurs elsewhere in the CPT set, including coaching CPT codes for other specialties.

Code details at a glance

Related FNA biopsy CPT codes: The 10004-10021 family

Effective January 1, 2019, the AMA restructured FNA biopsy coding to distinguish procedures by imaging modality and by lesion sequence (first lesion vs. each additional lesion). Before 2019, FNA coding was considerably less granular. The restructuring introduced paired base/add-on codes for each imaging type, replacing older codes that did not differentiate by guidance modality.

Understanding where CPT code 10010 sits within the full family prevents misrouting to the wrong imaging code. The same first-lesion/additional-lesion logic applies to every modality in the family, including the ultrasound-guided base code 10005.

When a patient has multiple suspicious lesions and the radiologist samples them in a single session using CT, only one base code (10009) applies regardless of how many total lesions are sampled. Each lesion after the first generates one unit of CPT code 10010.

Switching modalities mid-session (for example, using CT for one lesion and ultrasound for another) requires reporting the appropriate base code for each modality. Per NCCI Chapter 3 guidance, that additional base code needs Modifier 59 appended, since more than one primary/base code is being reported for the same session.

Any further lesions sampled under that second modality are then reported with its own modality-specific add-on code.

CPT 10010 billing rules: Add-on code requirements and NCCI edits

Add-on codes carry specific structural rules that differ from standalone procedure codes. CPT code 10010 cannot appear on a claim without CPT 10009 as the primary code. Submitting 10010 alone produces an automatic denial because payers recognize the “+” designation and require the parent code to be present on the same claim.

Reporting it for the first lesion also triggers denial. The descriptor explicitly states “each additional lesion.”

Reduce FNA claim denials with Pabau

Pabau's claims management tools help billing teams track add-on code pairings, flag missing documentation, and submit cleaner claims for imaging-guided procedures. See how it works in a live demo.

Book a demo

NCCI bundling restrictions

The National Correct Coding Initiative (NCCI) added a critical restriction for the entire FNA code family in 2019. Per NCCI Chapter 3, Section L12: FNA biopsies (CPT codes 10004-10012 and 10021) shall not be reported with a biopsy code for the same lesion.

This means a coder cannot bill CPT code 10010 alongside a separate core needle biopsy or incisional biopsy code when both procedures target the same lesion during the same session.

If a clinician performs an FNA and also takes a core biopsy of a different lesion, separate reporting may be appropriate, but same-lesion bundling is prohibited. Confirm current NCCI edits for any specific claim through the CMS Physician Fee Schedule lookup, as edits update annually.

The ICD-10-CM codes reported alongside CPT code 10010 must reflect the clinical indication driving the biopsy. Common pairings include malignant neoplasm codes such as C10.1, lymphadenopathy codes, or thyroid nodule codes, depending on the anatomical site. Payers may deny claims where the diagnosis code does not justify the medical necessity of CT-guided sampling.

Modifier rules for CPT code 10010

As an add-on code, CPT 10010 is exempt from Modifier 51 (multiple procedures). Do not append Modifier 51 to an add-on code. Modifier 59 (distinct procedural service) may be applicable in limited scenarios where a payer’s claims system incorrectly bundles 10010 with another procedure for a genuinely separate lesion, but this should be confirmed with the payer before use.

Place of Service (POS) coding follows the setting where the procedure occurs, typically hospital outpatient (POS 22) for most CT-guided procedures, though ambulatory surgical centers and office settings are also valid depending on equipment availability.

Documentation requirements for CPT code 10010

Imaging-guided CPT codes carry a documentation requirement that non-guided codes do not: permanently recorded images must be obtained during the procedure. If the procedure note does not confirm that CT images were permanently recorded and archived, the imaging guidance component of CPT code 10010 loses its justification.

Payers auditing these claims look specifically for language confirming image acquisition, not just a statement that CT was used for room positioning. For practices building consistent procedure documentation workflows, a standardized note template that explicitly captures imaging confirmation reduces audit exposure considerably.

Well-structured procedure notes for CT-guided FNA billing should document all of the following elements:

• Imaging modality: Confirm CT was used (not ultrasound or fluoroscopy) and that images were permanently recorded
• Number of lesions sampled: Identify each lesion separately, with anatomical location and laterality where applicable
• Needle type and approach: Document gauge, insertion technique, and number of passes per lesion
• Specimen handling: Note whether cytology or cell block preparation was obtained for each lesion
• Clinical indication: State the diagnosis or suspected diagnosis driving the procedure
• Patient consent: Confirm informed consent was obtained before the procedure
• Lesion sequence: Explicitly identify which lesion is the “first” and which are “additional” to support the base code / add-on code structure

Missing the lesion-sequence documentation is one of the most common triggers for post-payment audit recovery. If the note does not distinguish lesion order, the payer cannot verify that CPT code 10010 applies to a second (or subsequent) lesion rather than the first.

Practices using claims management software can build these documentation checkpoints into pre-submission workflows, flagging claims where the procedure note lacks required imaging confirmation fields before the claim leaves the practice.

CPT code 10010 reimbursement and Medicare fee schedule

Reimbursement for CPT code 10010 under the Medicare Physician Fee Schedule (MPFS) varies by geographic locality and by setting (facility vs. non-facility). As an add-on code representing the incremental work of sampling an additional CT-guided lesion, its relative value units (RVUs) are lower than the base code CPT 10009, which captures the primary setup and first-lesion work.

Specific dollar amounts change with each annual CMS update. Always verify current rates through the FastRVU 2026 RVU lookup or the CMS fee schedule rather than relying on static published figures.

New Mexico Health’s Breast and Cervical Cancer (BCC) program has published reimbursement at the rate for CPT code 10010 for certain screening-related FNA procedures, reflecting how state and payer-specific programs adopt Medicare rates as their baseline.

Prior authorization requirements add another reimbursement variable. Hill Physicians Medical Group, for example, designates CPT code 10010 as requiring prior authorization, marked “Y” in their published CPT code-level authorization document.

Prior authorization requirements vary widely by payer and geography. Checking authorization requirements before scheduling is part of the standard pre-service workflow across imaging-guided procedures generally, from CT-guided biopsy codes to contrast-enhanced studies such as 74177. Verify requirements with the specific health plan for each patient before the procedure date.

For practices wanting to look up current RVU values and national unadjusted rates, the AAPC Codify CPT lookup provides modifier-specific and facility/non-facility breakdowns.

Facility vs. non-facility reimbursement

CT-guided FNA procedures are almost always performed in a facility setting (hospital outpatient or ambulatory surgery center), which means the professional component reimbursement reflects the facility rate, typically lower than the non-facility rate because the facility separately bills a technical component.

Practices billing the global service (professional + technical) from an office-based CT suite will use the non-facility rate. Confirm which rate applies to your setting before calculating expected reimbursement, and document the Place of Service code accordingly on each claim.

Common denial reasons for CPT code 10010 and how to avoid them

Claims auditors see predictable patterns in FNA biopsy denials. Most are preventable with pre-submission review. The five denial types below account for the majority of CPT code 10010 rejections in practice:

For practices that perform dermatology or skin biopsy procedures alongside radiology referrals, dermatology practice software paired with skin clinic software that shares integrated billing workflows helps prevent the modality mismatch errors described above.

The same payer-check logic that catches missing prior authorizations in one specialty applies across all imaging-guided code families, including the no-imaging FNA base code 10021.

Conclusion

FNA biopsy claim denials cluster around a small number of avoidable errors: missing base codes, modality mismatches, inadequate imaging documentation, and NCCI bundling violations.

CPT code 10010 is precise in scope. It applies to CT-guided FNA only, for lesions beyond the first, and only when paired with CPT 10009. Getting those details right at charge entry prevents the rework that costs billing teams hours every month.

Pabau’s digital clinical forms and claims management tools help radiology and surgical practices build documentation standards and pre-submission checks directly into their workflows, so the right codes leave with the right supporting evidence every time. To see how Pabau handles procedure billing documentation for imaging-guided codes, book a demo.

Continue your research

Need to bill CT contrast media alongside imaging-guided procedures? A9575 is the billing code radiologists reference for contrast-enhanced studies.

Need ICD-10 pairing guidance for a related diagnosis? C19 covers documentation for a malignant neoplasm code commonly paired with image-guided biopsy claims.

Want to standardize procedure documentation across your practice? Our intake assessment template covers best practices for building compliant, auditable procedure notes.

Billing for oncology infusion therapy alongside diagnostic biopsy? J9312 is the billing code used across rheumatology and oncology claims.

Frequently Asked Questions